Report Categories
View AllRecent Articles
View All
DXCM DexCom beats Q1 estimates with 17 EPS surprise revenue climbs 156 YoY
Invesco Optimum Yield Diversified Commodity Strategy No K1 ETF PDBC 35 YeartoDate Rally Amid Uncertainty Over 2026 YearEnd Distribution
CrossAsset Market Volatility and US Equity Correction Risks Amid Escalating Iran Conflict
KTTA Pasithea Therapeutics shares climb 21 percent despite reporting a far wider than expected Q4 2025 per share loss
DEFSEC Q2 2024 Earnings Narrowerthanexpected loss fuels rally despite EPS miss
GreenPower GP Reports Q2 2025 In Line Steady Performance Continues
Why Prothena PRTA Just Surged 221 Key Levels Ahead 20260520
Karbon Capital Partners Corp Warrant KBONW Holds Steady at 058 Amid Tight Trading Range